These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of worsening renal function during hospital admission on resource utilization in patients with heart failure. Herout PM, Harshaw Q, Phatak H, Saka G, McNeill A, Wu D, Sazonov V, DeSagun R, Shirani J. Am J Cardiol; 2010 Oct 15; 106(8):1139-45. PubMed ID: 20920654 [Abstract] [Full Text] [Related]
3. Impact of worsening renal function related to medication in heart failure. Brunner-La Rocca HP, Knackstedt C, Eurlings L, Rolny V, Krause F, Pfisterer ME, Tobler D, Rickenbacher P, Maeder MT, TIME‐CHF investigators. Eur J Heart Fail; 2015 Feb 15; 17(2):159-68. PubMed ID: 25808849 [Abstract] [Full Text] [Related]
4. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM, O'Connor CM, Rich MW, Stevenson LW, Wang Y, Young JB, Krumholz HM. Am Heart J; 2004 Feb 15; 147(2):331-8. PubMed ID: 14760333 [Abstract] [Full Text] [Related]
8. Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure. Kociol RD, Greiner MA, Hammill BG, Phatak H, Fonarow GC, Curtis LH, Hernandez AF. Am J Cardiol; 2010 Jun 15; 105(12):1786-93. PubMed ID: 20538131 [Abstract] [Full Text] [Related]
9. Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). Vardeny O, Wu DH, Desai A, Rossignol P, Zannad F, Pitt B, Solomon SD, RALES Investigators. J Am Coll Cardiol; 2012 Nov 13; 60(20):2082-9. PubMed ID: 23083787 [Abstract] [Full Text] [Related]
10. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure). Eschalier R, McMurray JJ, Swedberg K, van Veldhuisen DJ, Krum H, Pocock SJ, Shi H, Vincent J, Rossignol P, Zannad F, Pitt B, EMPHASIS-HF Investigators. J Am Coll Cardiol; 2013 Oct 22; 62(17):1585-93. PubMed ID: 23810881 [Abstract] [Full Text] [Related]
12. Interaction between worsening renal function and persistent congestion in acute decompensated heart failure. Wattad M, Darawsha W, Solomonica A, Hijazi M, Kaplan M, Makhoul BF, Abassi ZA, Azzam ZS, Aronson D. Am J Cardiol; 2015 Apr 01; 115(7):932-7. PubMed ID: 25700802 [Abstract] [Full Text] [Related]
19. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN. Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651 [Abstract] [Full Text] [Related]
20. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy. Muzzarelli S, Maeder MT, Toggweiler S, Rickli H, Nietlispach F, Julius B, Burkard T, Pfisterer ME, Brunner-La Rocca HP, TIME-CHF Investigators. Am J Cardiol; 2012 Mar 01; 109(5):693-8. PubMed ID: 22152974 [Abstract] [Full Text] [Related] Page: [Next] [New Search]